Leuprolide Active Not Recruiting Phase 3 Trials for Hormone Sensitive Prostate Cancer / Prostate Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02319837Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT00430183Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
NCT00116220Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer
NCT00005044Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
NCT01546987Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
NCT00055731Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
NCT00936390Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer